204 related articles for article (PubMed ID: 23503045)
21. Caveolin-1 in Cardiovascular Disease: A Double-Edged Sword.
Jia G; Sowers JR
Diabetes; 2015 Nov; 64(11):3645-7. PubMed ID: 26494216
[No Abstract] [Full Text] [Related]
22. Potential manipulation of endothelial progenitor cells in diabetes and its complications.
Fadini GP; Avogaro A
Diabetes Obes Metab; 2010 Jul; 12(7):570-83. PubMed ID: 20590732
[TBL] [Abstract][Full Text] [Related]
23. Amorphous nano-selenium quantum dots improve endothelial dysfunction in rats and prevent atherosclerosis in mice through Na
Zhu ML; Wang G; Wang H; Guo YM; Song P; Xu J; Li P; Wang S; Yang L
Vascul Pharmacol; 2019 Apr; 115():26-32. PubMed ID: 30695730
[TBL] [Abstract][Full Text] [Related]
24. Response to Buscemi S et al. Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes.
Zaccardi F; Pitocco D; Caputo S; Ghirlanda G
Diabet Med; 2011 Jan; 28(1):126; author reply 127-8. PubMed ID: 21166858
[No Abstract] [Full Text] [Related]
25. Endothelial damage and stem cell repair in atherosclerosis.
Bai X; Wang X; Xu Q
Vascul Pharmacol; 2010; 52(5-6):224-9. PubMed ID: 20156585
[TBL] [Abstract][Full Text] [Related]
26. Targeting the endothelium to prevent diabetes-related atherosclerosis.
Kearney MT
Diab Vasc Dis Res; 2010 Jul; 7(3):177. PubMed ID: 20699387
[No Abstract] [Full Text] [Related]
27. The promise of EPC-based therapies on vascular dysfunction in diabetes.
Georgescu A; Alexandru N; Constantinescu A; Titorencu I; Popov D
Eur J Pharmacol; 2011 Nov; 669(1-3):1-6. PubMed ID: 21839073
[TBL] [Abstract][Full Text] [Related]
28. Atherosclerosis and the Capillary Network; Pathophysiology and Potential Therapeutic Strategies.
Ziegler T; Abdel Rahman F; Jurisch V; Kupatt C
Cells; 2019 Dec; 9(1):. PubMed ID: 31878229
[TBL] [Abstract][Full Text] [Related]
29. Direct Endothelial Nitric Oxide Synthase Activation Provides Atheroprotection in Diabetes-Accelerated Atherosclerosis.
Sharma A; Sellers S; Stefanovic N; Leung C; Tan SM; Huet O; Granville DJ; Cooper ME; de Haan JB; Bernatchez P
Diabetes; 2015 Nov; 64(11):3937-50. PubMed ID: 26116699
[TBL] [Abstract][Full Text] [Related]
30. Relationship between circulating endothelial progenitor cells and endothelial dysfunction in children with type 1 diabetes: a novel paradigm of early atherosclerosis in high-risk young patients.
Głowińska-Olszewska B; Moniuszko M; Hryniewicz A; Jeznach M; Rusak M; Dąbrowska M; Łuczyński W; Bodzenta-Łukaszyk A; Bossowski A
Eur J Endocrinol; 2013 Feb; 168(2):153-61. PubMed ID: 23111589
[TBL] [Abstract][Full Text] [Related]
31. Endothelial cell dysfunction as a novel therapeutic target in atherosclerosis.
Jensen HA; Mehta JL
Expert Rev Cardiovasc Ther; 2016 Sep; 14(9):1021-33. PubMed ID: 27362558
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of angiopathy in diabetes.
Skrha J
Acta Diabetol; 2003 Dec; 40 Suppl 2():S324-9. PubMed ID: 14704862
[TBL] [Abstract][Full Text] [Related]
33. [Atherothrombosis in patients with type 2 diabetes mellitus: an overview of pathophysiology].
Mafrici A; Proietti R
G Ital Cardiol (Rome); 2010 Jun; 11(6):467-77. PubMed ID: 20922872
[TBL] [Abstract][Full Text] [Related]
34. Review of gestational diabetes mellitus effects on vascular structure and function.
Jensen LA; Chik CL; Ryan EA
Diab Vasc Dis Res; 2016 May; 13(3):170-82. PubMed ID: 26940821
[TBL] [Abstract][Full Text] [Related]
35. Deficiency of the complement regulatory protein CD59 accelerates the development of diabetes-induced atherosclerosis in mice.
Liu F; Sahoo R; Ge X; Wu L; Ghosh P; Qin X; Halperin JA
J Diabetes Complications; 2017 Feb; 31(2):311-317. PubMed ID: 27729184
[TBL] [Abstract][Full Text] [Related]
36. Molecular insights and therapeutic targets for diabetic endothelial dysfunction.
Xu J; Zou MH
Circulation; 2009 Sep; 120(13):1266-86. PubMed ID: 19786641
[No Abstract] [Full Text] [Related]
37. Noncoding RNAs as therapeutic targets in atherosclerosis with diabetes mellitus.
Tang N; Jiang S; Yang Y; Liu S; Ponnusamy M; Xin H; Yu T
Cardiovasc Ther; 2018 Aug; 36(4):e12436. PubMed ID: 29797660
[TBL] [Abstract][Full Text] [Related]
38. The morphological and molecular mechanisms of epithelial/endothelial-to-mesenchymal transition and its involvement in atherosclerosis.
Wesseling M; Sakkers TR; de Jager SCA; Pasterkamp G; Goumans MJ
Vascul Pharmacol; 2018 Jul; 106():1-8. PubMed ID: 29471141
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis of hypertension in diabetes.
Stas SN; El-Atat FA; Sowers JR
Rev Endocr Metab Disord; 2004 Aug; 5(3):221-5. PubMed ID: 15211093
[No Abstract] [Full Text] [Related]
40. Organelle dynamics of endothelial mitochondria in diabetic angiopathy.
Xiang H; Song R; Ouyang J; Zhu R; Shu Z; Liu Y; Wang X; Zhang D; Zhao J; Lu H
Eur J Pharmacol; 2021 Mar; 895():173865. PubMed ID: 33460616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
